Combined effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid and anti-CD20 monoclonal antibody rituximab on mantle cell lymphoma cells apoptosis. [electronic resource]
Producer: 20120618Description: 749-55 p. digitalISSN:- 1873-5835
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antigens, CD20 -- immunology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Drug Synergism
- Histone Deacetylase Inhibitors -- administration & dosage
- Humans
- Hydroxamic Acids -- administration & dosage
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Mice
- Mice, SCID
- Rituximab
- Vorinostat
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.